This inventor holds 2 USPTO granted patents. Top assignee: Pierre Fabre S.a.. Active years: 1976-1982.
Location History:
- Paris, FR (1976)
- Mazamet, FR (1982)
Company Filing History:
Years Active: 1976-1982
Title: The Innovations of Hubert Serre
Introduction
Hubert Serre is a notable inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the development of vaccines and medicaments. With a total of 2 patents, his work has the potential to impact public health positively.
Latest Patents
One of Hubert Serre's latest patents is a process for preparing vaccines based on antigenic ribosomal fractions. This innovative vaccine comprises the ribosomal fraction extracted from the bacteria against which protection is sought, along with peptidoglycanes extracted from the membranes of at least one of the bacteria previously used. Another significant patent involves medicaments intended for the prevention and treatment of ischemic conditions. This invention focuses on new compositions that contain vasodilators or vasoregulators and substances that decrease the adhesiveness and aggregability of blood platelets. These compositions are useful for preventing and treating circulatory insufficiency, regardless of its location.
Career Highlights
Hubert Serre is associated with Pierre Fabre S.A., a company known for its commitment to innovation in healthcare. His work at this organization has allowed him to focus on developing groundbreaking medical solutions that address critical health issues.
Collaborations
Throughout his career, Hubert has collaborated with esteemed colleagues such as Lucien D D'Hinterland and Gerard Normier. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful medical inventions.
Conclusion
Hubert Serre's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving health outcomes. His innovative work continues to pave the way for advancements in vaccine and medicament development.
